PD Dr. med. Martin Hümmert
Personal profile
Qualifications
- Specialist in neurology
- Investigator for clinical studies
- Decentralized data protection contact person for the Clinical Department
Clinical focus
- Diagnosis and treatment of AQP4 antibody-positive neuromyelitis optica spectrum diseases (AQP4-IgG+ NMOSD)
- Diagnosis and treatment of antibody-negative neuromyelitis optica spectrum diseases (Ak- NMOSD)
- Diagnosis and treatment of MOG-IgG antibody-associated diseases (MOGAD)
- Diagnosis and treatment of all other neuroimmunological diseases
- Cerebrospinal fluid diagnostics
Main areas of research
Management of numerous national and international multicenter studies:
- Optimization of long-term and relapse therapy for demyelinating CNS diseases
- Investigation of cognition in NMOSD and MOGAD (CogniNMO study, CogniMOG study)
- Effects of late onset of neuroimmunological diseases
- Investigation of the costs of illness and quality of life including the overall social perspective of rare diseases using the example of NMOSD and MOGAD (CHANCE-NMO study)
- Investigation of pandemic effects on rare diseases using the example of NMOSD and MOGAD (COPANMO(G) study)
- Biomarkers for diagnosis, prognosis and therapy decisions in neuroimmunological diseases
- Caregiver burden in NMOSD and MOGAD
Establishment and expansion of registry database for NMOSD and MOGAD
Many years of study experience (Phase II-IV and IITs) in neurological diseases
Research funding
- NEMOS e. V. project funding (NegMO study)
Publications:
- Pubmed Link: pubmed.ncbi.nlm.nih.gov
Memberships
- German Society for Neurology (DGN)
- Neuromyelitis optica study group (NEMOS) e. V. (founding member, board member and secretary)
- Medical and scientific advisory board of the national self-help group Myelitis e. V.
- Medical Professional Network of the international self-help group Siegel Rare Neuroimmune Association (SRNA)
- German Society for CSF Diagnostics and Clinical Neurochemistry (DGLN)
- Young Liquorology of the DGLN
- Centre for Rare Diseases (ZSE) of the MHH
- MOGAD Eugène Devic European Network (MEDEN)